# Exhaled Breath Condensate (EBC) Assessment in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

> **NCT00448500** · — · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 80 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00448500
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2008-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00448500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00448500, "Exhaled Breath Condensate (EBC) Assessment in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00448500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
